Zoetis (ZTS) Change in Account Payables (2014 - 2026)
Zoetis (ZTS) reported Change in Account Payables of $62.0 million for Q1 2026, up 181.82% year-over-year from $22.0 million in Q1 2025, and down 18.42% quarter-over-quarter from $76.0 million in Q4 2025.
Zoetis (ZTS) Change in Account Payables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Change in Account Payables data on file, last reported at $62.0 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $62.0 million, up 181.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.0 million (up 53.57% YoY), and the FY2025 annual result was $46.0 million, up 48.39% from the prior year.
- Change in Account Payables declined to $62.0 million in Q1 2026 per ZTS's latest filing, from $76.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $76.0 million in Q4 2025 and troughed at -$74.0 million in Q3 2023.
- A 5-year average of $7.2 million and a median of $22.0 million in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables slumped 365.0% in 2022, then soared 833.33% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $30.0 million in 2022, then declined by 26.67% to $22.0 million in 2023, then climbed by 18.18% to $26.0 million in 2024, then jumped by 192.31% to $76.0 million in 2025, then decreased by 18.42% to $62.0 million in 2026.
- Business Quant data shows ZTS's Change in Account Payables at $62.0 million in Q1 2026, $76.0 million in Q4 2025, and -$54.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 190,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 167.64 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Sep 30, 2025 | -54.00 Mn |
| Sep 30, 2025 | -54.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | 23.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | 22.00 Mn |
| Dec 31, 2023 | 22.00 Mn |